Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
Titel:
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
Auteur:
Zhao, C. Miao, J. Shen, G. Li, J. Shi, M. Zhang, N. Hu, G. Chen, X. Hu, X. Wu, S. Chen, J. Shao, X. Wang, L. Han, F. Mai, H. Chua, M.L.K. Xie, C.